Luna Innovations Inc's Cash & cash equivalent grew by 83.95 % in the Q3 2023 sequentially, faster than Current Liabilities, this led to improvement in Luna Innovations Inc's Quick Ratio to 0.17, Quick Ratio remained below Luna Innovations Inc average.

Within Medical Laboratories industry 43 other companies have achieved higher Quick Ratio than Luna Innovations Inc in third quarter 2023. While Quick Ratio total ranking in the third quarter 2023 has deteriorated compared to the prior quarter from 3156 to 4238.

Explain Quick Ratio?
How much Cash & cash equivalents LUNA�s has?
What are LUNA�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

LUNA Quick Ratio	(Sep 30 2023) Q3	(Jun 30 2023) Q2	(Mar 31 2023) Q1	(Dec 31 2022) Q4	(Sep 30 2022) Q3
Y / Y Current Liabilities Change	3.51 %	1.64 %	6.73 %	-4.88 %	0.49 %
Y / Y Cash & cash equivalent Change	-23.59 %	-32.63 %	-67.01 %	-64.83 %	-46.53 %
Quick Ratio MRQ	0.17	0.11	0.11	0.19	0.23
LUNA's Total Ranking	# 4238	# 3156	# 3476	# 3395	#
Seq. Current Liabilities Change	16.53 %	-8.01 %	5.04 %	-8.07 %	14.42 %
Seq. Cash & cash equivalent Change	83.95 %	-7.92 %	-40.92 %	-23.64 %	62.19 %

Quick Ratio third quarter 2023 Company Ranking
Within:	No.
Medical Laboratories Industry	# 44
Healthcare Sector	# 1046
Overall Market	# 4238

Quick Ratio Statistics
High	Average	Low
4.71	1.33	0.11
(Sep 30 2018)		(Mar 31 2023)

Financial Statements
Luna Innovations Inc's Current Liabilities	$ 35 Millions	Visit LUNA's Balance sheet
Luna Innovations Inc's Cash & cash equivalent	$ 6 Millions	Visit LUNA's Balance sheet
Source of LUNA's Sales		Visit LUNA's Sales by Geography

Cumulative Luna Innovations Inc's Quick Ratio

LUNA's Quick Ratio for the trailling 12 Months

LUNA Quick Ratio	(Sep 30 2023) 12 Months	(Jun 30 2023) 12 Months	(Mar 31 2023) 12 Months	(Dec 31 2022) 12 Months	(Sep 30 2022) 12 Months
Y / Y Current Liabilities TTM Growth	1.68 %	0.88 %	1.68 %	2.6 %	8.33 %
Y / Y Cash & cash equivalent TTM Growth	-53.56 %	-56.35 %	-59.12 %	-46.87 %	-24.53 %
Quick Ratio TTM	0.15	0.16	0.18	0.24	0.32
Total Ranking TTM	# 4456	# 3942	# 3585	# 4023	#
Seq. Current Liabilities TTM Growth	0.93 %	0.38 %	1.65 %	-1.26 %	0.13 %
Seq. Cash & cash equivalent TTM Growth	-8.97 %	-7.11 %	-24.45 %	-27.3 %	-14.44 %

Quick ratio ranking by company, industry and sector >> Back to LUNA Financial Strength Comparisons >> Go to Compare LUNA Quick Ratio to its Competitors

On the trailing twelve months basis Due to increase in Current Liabilities in the Q3 2023 to $35.01 millions, cumulative Quick Ratio decreased to 0.15 below the Luna Innovations Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 51 other companies have achieved higher Quick Ratio than Luna Innovations Inc. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2023 from 3942 to 4456.

Explain Quick Ratio?
How much Cash & cash equivalents LUNA�s has?
What are LUNA�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Laboratories Industry	# 52
Healthcare Sector	# 1130
Within the Market	# 4456

trailing twelve months Quick Ratio Statistics
High	Average	Low
3.28	1.32	0.16
(Dec 31 2018)		(Jun 30 2023)

Companies with similar Quick Ratio in the quarter ending Sep 30 2023, within Medical Laboratories Industry	Quick Ratio	Sep 30 2023 MRQ Cash & cash equivalent	Sep 30 2023 MRQ Current Liabilities
Centogene N v	0.44	$ 21.391 Millions	$ 48.570 Millions
Psychemedics Corporation	0.32	$ 1.370 Millions	$ 4.327 Millions
Medpace Holdings Inc	0.29	$ 95.207 Millions	$ 329.763 Millions
Iqvia Holdings Inc	0.28	$ 1,332.000 Millions	$ 4,751.000 Millions
Labcorp Holdings Inc	0.25	$ 727.900 Millions	$ 2,900.800 Millions
Koninklijke Philips Nv	0.25	$ 2,339.680 Millions	$ 9,517.760 Millions
Fortrea Holdings Inc	0.22	$ 107.500 Millions	$ 490.200 Millions
Charles River Laboratories International inc	0.21	$ 157.174 Millions	$ 743.331 Millions
Luna Innovations Inc	0.17	$ 6.028 Millions	$ 35.010 Millions
Icon Plc	0.11	$ 315.019 Millions	$ 2,818.188 Millions
Quest Diagnostics Inc	0.10	$ 143.000 Millions	$ 1,461.000 Millions
Nrc Health	0.09	$ 3.828 Millions	$ 40.805 Millions
Aclarion Inc	0.07	$ 0.161 Millions	$ 2.160 Millions

Date modified: 2026-09-08T15:11:07+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.